Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1620
-0.0210 (-11.48%)
Feb 13, 2026, 4:08 PM HKT

HKG:6833 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
232.63308.32437.92329.14326.05143.77
Cash & Short-Term Investments
232.63308.32437.92329.14326.05143.77
Cash Growth
-17.51%-29.59%33.05%0.95%126.79%-35.17%
Accounts Receivable
727.07608.25540.51351.27213.6578.69
Other Receivables
59.9173.1451.8837.7410.358.52
Receivables
786.98681.39592.38389.01223.96587.2
Inventory
274.04352.53108.0389.5862.76242.56
Prepaid Expenses
----1.30.81
Restricted Cash
22.11103.06220.03107.8555.02-
Other Current Assets
72.5366.9174.93101.82299.931.39
Total Current Assets
1,3881,5121,4331,017968.981,006
Property, Plant & Equipment
364.46371.36354.21315.84256.26238.18
Goodwill
66.5466.5466.5466.54--
Other Intangible Assets
49.5311.8114.0315-0.02
Long-Term Deferred Tax Assets
5.172.423.430.860.65
Long-Term Deferred Charges
-30.1413.08---
Other Long-Term Assets
5.875.966.146.556.677.48
Total Assets
1,8802,0001,8911,4241,2331,252
Accounts Payable
919.56887.97866.59407.99422.93700.32
Accrued Expenses
15.3714.6717.1386.1117.49127.3
Short-Term Debt
-340240180.81207.5177.16
Current Portion of Long-Term Debt
221.620.860.86-0.810.83
Current Portion of Leases
4.65.143.8330.380.74
Current Income Taxes Payable
15.1520.5926.445.4412.8322
Current Unearned Revenue
9.8627.7340.4675.4327.7527.81
Other Current Liabilities
7.2934.736.7331.8235.9334.65
Total Current Liabilities
1,1931,3321,232790.59725.64990.79
Long-Term Debt
-0.050.890.92132.243.04
Long-Term Leases
1.684.495.837.69-0.37
Long-Term Deferred Tax Liabilities
1.131.351.82.25--
Other Long-Term Liabilities
--22.0819.08-93.42
Total Liabilities
1,1961,3381,263820.52857.881,088
Common Stock
0.160.160.160.160.150.14
Additional Paid-In Capital
529.48529.48529.48529.48370.02293.36
Retained Earnings
153.96133.2498.4174.170.48-135.08
Comprehensive Income & Other
----4.236.92
Total Common Equity
683.6662.88628.05603.81374.89165.34
Minority Interest
------0.91
Shareholders' Equity
683.6662.88628.05603.81374.89164.43
Total Liabilities & Equity
1,8802,0001,8911,4241,2331,252
Total Debt
227.9350.54251.4192.41340.9582.13
Net Cash (Debt)
4.73-42.22186.52136.73-14.961.63
Net Cash Growth
--36.41%--86.29%
Net Cash Per Share
0.00-0.020.090.07-0.010.04
Filing Date Shares Outstanding
2,0332,0332,0332,0331,8731,692
Total Common Shares Outstanding
2,0332,0332,0332,0331,8731,692
Working Capital
194.84180.55201.25226.82243.3414.93
Book Value Per Share
0.340.330.310.300.200.10
Tangible Book Value
567.53584.53547.49522.28374.89165.32
Tangible Book Value Per Share
0.280.290.270.260.200.10
Land
-----175.16
Buildings
-214.5196.87197.31197.31-
Machinery
-58.8925.9822.9420.0620.03
Construction In Progress
-68.04107.384.5833.531.24
Leasehold Improvements
-36.3213.6711.1911.0810.95
Source: S&P Global Market Intelligence. Standard template. Financial Sources.